Navigation Links
Positive Results for Investigational Compound Lyxumia® (Lixisenatide) Presented at American Diabetes Association's 71st Annual Scientific Sessions
Date:6/24/2011

6 kg/m2 and mean A1C 8.0 percent.

Key Findings:

  • Lixisenatide once daily achieved its primary endpoint of  non-inferiority in A1C reduction versus exenatide twice daily (LS mean +/- SE change from baseline: -0.79 +/- 0.05 vs. -0.96 +/- 0.05)
  • Improvements in mean fasting plasma glucose – measurement of blood glucose levels when a patient is fasting – (LS mean +/- SE change from baseline: -22.0 +/- 2.1 vs. -26.1 +/- 2.1) and the percentage of patients achieving the study target A1C < 7.0 percent (48.5% vs. 49.8%) were comparable between groups
  • Mean body weight significantly decreased from baseline in the lixisenatide group compared to the exenatide group (94.5 to 91.7 kg with lixisenatide vs. 96.7 to 92.9 kg with exenatide)
  • The proportion of patients with serious adverse events was generally comparable between groups
  • Discontinuations due to adverse events (mainly gastrointestinal events including nausea, diarrhea and vomiting) were 33 (10.4%) in the lixisenatide group and 41 (13.0%) in the exenatide group
  • Significantly fewer patients experienced symptomatic hypoglycemia with lixisenatide (2.5% vs. 7.9%, p<0.05), with 6-fold fewer hypoglycemic events (8 vs. 48) versus exenatide
  • More lixisenatide patients tolerated the target dose of 20 microgram per day and completed the trial versus the exenatide 10 mcg target dose (93% vs. 83%)

  • "Lixisenatide  Significantly  Improves  Glycemic  Control  in  Asian  Patients   with  Type  2 Diabetes Insufficiently Controlled on Basal Insulin +/- Sulfonylurea" [ABSTRACT 0278-OR]Data from the GetGoal-L Asia trial, showed in  Asian patients with type 2 diabetes insufficiently controlled by basal insulin +/- sulfonylurea, that lixisenatide once daily significantly improved glycemic control (as  measured by the number of patients reaching  a target A1C < 6.5 percent or
    '/>"/>

    SOURCE Euro RSCG Life
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8

    Related medicine technology :

    1. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
    2. Positive Kuvan(TM) Pivotal Phase 3 Trial Results Published in The Lancet
    3. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
    4. MicroDose Announces Positive Results From the QDose Inhaled Insulin Glucose Clamp Study
    5. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
    6. NeurogesX Announces Positive Results from Second Phase 3 Clinical Trial in Postherpetic Neuralgia
    7. TAXUS WOMAN Study Reports Positive Clinical Outcomes for the TAXUS(R) Drug-eluting Stent in Women
    8. Nabi Biopharmaceuticals Announces Continued Positive NicVAX Phase 2b Data at Nine Months
    9. Kosans Second-Generation Hsp90 Inhibitor, Alvespimycin, Shows 42% Clinical Benefit in Phase 1 HER2-Positive Metastatic Breast Cancer Trial
    10. Pharmacopeia Announces Positive Results from Phase 1 Multiple Ascending Dose Study of PS433540 (DARA)
    11. European Unions CHMP Issues Positive Opinion on PEGINTRON(TM) Combination Therapy for Retreating Hepatitis C Patients Who Failed Previous Therapy
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:4/24/2015)... N.C. , April 24, 2015  New ... ability of consumers to educate themselves about products ... the tools and techniques available to market researchers ... the changing consumer marketplace, it,s imperative that organizations ... to better identify market opportunities, niches and growth ...
    (Date:4/24/2015)... MARLBOROUGH, Mass. , April 24, 2015 Boston ... in the Deutsche Bank 40 th Annual Healthcare Conference ... Dan Brennan , executive vice president and chief ... Relations, will participate in a 35-minute question and answer session ... a.m. ET. A live webcast of the presentation ...
    (Date:4/24/2015)... , April 24, 2015  Novartis Pharmaceuticals Corporation (NPC) ... second year in a row on the annual DiversityInc Top ... its 2015 Top 50 Companies for Diversity on April 23 ... . NPC also ranked second on the DiversityInc Top ... 10 Companies for Employee Resource Groups list. ...
    Breaking Medicine Technology:Pharmaceutical Industry Using New Technologies to Adjust Their Marketing and Research Approaches for Consumers 2Boston Scientific To Participate In The Deutsche Bank 40th Annual Healthcare Conference 2Novartis Pharmaceuticals Corporation is first company to receive number one ranking two years in a row on DiversityInc Top 50 Companies for Diversity list 2Novartis Pharmaceuticals Corporation is first company to receive number one ranking two years in a row on DiversityInc Top 50 Companies for Diversity list 3Novartis Pharmaceuticals Corporation is first company to receive number one ranking two years in a row on DiversityInc Top 50 Companies for Diversity list 4
    ... 2011 /PRNewswire-Asia-FirstCall/ -- American Oriental Bioengineering, Inc. (NYSE: ... company dedicated to improving health through the development, manufacture ... over the counter ("OTC") products, today announced that it ... financial results on Monday, March 14, 2011, after the ...
    ... China, March 4, 2011 /PRNewswire-Asia-FirstCall/ -- ... WKBT ) ("Weikang" or the "Company"), a ... (TCM), Western prescription and OTC pharmaceuticals and other health ... today announced that the Company will be presenting at ...
    Cached Medicine Technology:American Oriental Bioengineering to Announce Fourth Quarter and Full Year 2010 Financial Results on March 14, 2011 2Weikang Bio-Technology to Present at Rodman & Renshaw Annual China Investment Conference 2
    (Date:4/26/2015)... FL (PRWEB) April 26, 2015 A ... pieces of medical equipment from hospitals, surgery centers and ... of equipment will be sold including radiology, surgery, endoscopy, ... live auction will take place Tuesday, April 28th starting ... Lauderdale warehouse located at 5025 North Hiatus Rd., Sunrise, ...
    (Date:4/26/2015)... New York (PRWEB) April 26, 2015 ... popular events of the season and will include a ... like purses, totes, collectibles, herbal soaps and incense, chimes, ... While browsing this year’s exciting and unique collection of ... their afternoon with Jim Martocci and the Jimmie Jazz ...
    (Date:4/26/2015)... 26, 2015 Forbes Living is ... is one which is synonymous with clean beaches, sparkling office ... education are major economic influencers in the city on the ... talk show are pleased to announce the show will be ... at 3:00 PM PDT. Tune in to find out what ...
    (Date:4/26/2015)... MidSouth Pain Treatment Center has ... Pain Treatment Center is a comprehensive pain management center ... Jackson, two ambulatory surgery centers in Germantown and Southaven, ... locations. , Dr. Michael Steuer , founder of ... help people, and when I discovered that I could ...
    (Date:4/25/2015)... 2015 Diversified Communications has announced ... event. The Integrative Healthcare Symposium Canada, as it’s ... at the Sheraton Parkway Toronto North in Ontario. ... of the most anticipated events of the year ... program. The event aims to gather multi-disciplined practitioners ...
    Breaking Medicine News(10 mins):Health News:Centurion Service Group to Auction off 1,200 Lots of Medical Equipment 2Health News:It’s Coming! The 5th Annual Tulip Festival & Mother’s Day Celebration at Honor's Haven Resort & Spa! 2Health News:Forbes Living TV Will Air in San Diego, California 2Health News:Growing Pains for MidSouth Pain Treatment Center 2Health News:Integrative Healthcare Event launching in Canada 2
    ... 5 in the February 2008 edition (Volume 6, Issue ... team found that the hypertension drugs diltiazem and verapamil ... with the conditions Gaucher disease, -mannosidosis, and type IIIA ... reprogramming the innate protein homeostasis machinery of the cell ...
    ... WASHINGTON, Feb. 4 "Congress must reject,President Bush,s Fiscal ... needs of the over 1.1 million people living with ... Director of The AIDS,Institute. "Most of the people who ... are very poor and from minority communities.,As the richest ...
    ... largest of its kind , , MONDAY, Feb. 4 (HealthDay News) ... link between the measles, mumps and rubella (MMR) vaccine and ... theirs was the third and largest study that has looked ... has failed to find one. , "I think it,s fabulous ...
    ... Gilbert Hospital is,celebrating its second anniversary. Gilbert,s first ... more than 93,000 patients and has a,staff exceeding 350. ... room wait times of less than 31 minutes, Gilbert,Hospital ... this pledge,more than 98.5 percent of the time. "There ...
    ... Feb. 4 - President George W.,Bush today submitted ... 2009.,In response Bruce Roberts, RPh, executive vice president ... issued the following,statement:, "President Bush,s efforts to ... health care, and even more specifically the Medicare,and ...
    ... a consulting firm,dedicated exclusively to improving the pharmacy ... the recent,introduction of the ARMSRx E-Audit, their upgraded ... often overlooked piece of the prescription,benefits package. The ... of opportunities in which errors can occur. Fraud, ...
    Cached Medicine News:Health News:Scripps scientists find calcium channel blockers help normalize lysosomal storage disease cells 2Health News:Scripps scientists find calcium channel blockers help normalize lysosomal storage disease cells 3Health News:Scripps scientists find calcium channel blockers help normalize lysosomal storage disease cells 4Health News:President's FY09 Budget - A Disaster for Domestic AIDS: Congress Must Fund Critical Healthcare Priorities 2Health News:President's FY09 Budget - A Disaster for Domestic AIDS: Congress Must Fund Critical Healthcare Priorities 3Health News:Another Study Finds No Link Between MMR Vaccine and Autism 2Health News:Another Study Finds No Link Between MMR Vaccine and Autism 3Health News:Gilbert Hospital Turns Two 2Health News:NCPA Statement in Response to President Bush's FY 2009 Budget Proposal 2Health News:ARMSRx Tackles the New Rx Addiction -- Pharmacy Benefit Audits 2
    ... Vitamin D kit is an enzymeimmunoassay for ... hydroxylated metabolites in serum or plasma. Calibrators, ... labelled 25-OH D. The diluted samples are ... with a highly specific sheep 25-OH D ...
    ... for the control of glucose metabolism. It ... of Langerhans as the precursor, proinsulin, which is ... are secreted in equimolar amounts into the portal ... of two polypeptide chains, the A-chain and B-chain ...
    ... is an integral part of the enzymatic ... II as well as the degradation of ... ACE is primarily located in endothelial cells. ... parameter for sarcoidosis and myocardial infarction but ...
    ... Retinol binding Proetin (RBP) is small (21kD) ... complex with pre-albumin in blood but loses ... been deliverd to the target cells. The ... the glomerulus and catabolized in the,renal tubules ...
    Medicine Products: